<DOC>
	<DOCNO>NCT01529203</DOCNO>
	<brief_summary>The aim study assess subject ' satisfaction link pan facial management rejuvenation injection Azzalure速 Restylane速 filler . This open , multi-centre study .</brief_summary>
	<brief_title>Subjects ' Satisfaction Pan Facial Aesthetic Enhancement After Treatment With Azzalure速 Restylane速 Range</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Main Male female subject , age 18 64 year , seek treatment correction dynamic wrinkle upper third face correction facial volume loss , meet specific eligibility criterion Main Female subject pregnant , nurse plan pregnancy study Subject contraindication injection hyaluronic acid ( see package insert ) Subject contraindication injection botulinum toxin ( see package insert ) Subject personal history allergic/anaphylactic reaction include hypersensitivity crossedlinked hyaluronic acid botulinum toxin Concurrent treatment , investigator 's opinion , would interfere evaluation safety efficacy least one study treatment Subject history dissatisfaction facial aesthetic procedure involve dermal implant injection subject unattainable expectation Subject currently enrol another investigational study participate study past 30 day prior baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>